Comparative efficacy and discontinuation of dimethyl fumarate and fingolimod in clinical practice at 12-month follow-up.

Carrie M. Hersh,T. Love,Samuel Cohn,C. Hara-Cleaver,R. Bermel,R. Fox,Jeffrey A. Cohen,D. Ontaneda
DOI: https://doi.org/10.1016/j.msard.2016.08.002
IF: 4.808
2016-11-01
Multiple Sclerosis and Related Disorders
Abstract:
What problem does this paper attempt to address?